Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

SF3B1 -mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

Blood (2020) 136 (2): 157–170.

https://doi.org/10.1182/blood.2020004850

Published: 2020

Journal Articles

Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas

Salvia Jain, Alexandria Van Scoyk, Elizabeth A. Morgan, Andrew Matthews, Kristen Stevenson, Gail Newton, Foster Powers, Anu Autio, Abner Louissaint, Jr, Guillemette Pontini, Jon C. Aster, Francis W. Luscinskas, David M. Weinstock

Blood (2019) 134 (17): 1430–1440.

https://doi.org/10.1182/blood.2019001744

Published: 2019

Includes: Supplemental data

Journal Articles

RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice

Samuel Y. Ng, Leon Brown, Kristen Stevenson, Tiffany deSouza, Jon C. Aster, Abner Louissaint, Jr, David M. Weinstock

Blood (2018) 132 (9): 935–947.

https://doi.org/10.1182/blood-2017-11-818617

Published: 2018

Includes: Supplemental data

Journal Articles

Patients over Age 40 with Ph-Negative Acute Lymphoblastic Leukemia Do Not Benefit from Allogeneic Transplant in First Remission. Retrospective Analysis from a Large Tertiary Center

Ofir Wolach, MD, Kristen Stevenson, MS, Martha Wadleigh, MD, Daniel J. DeAngelo, MD PhD, David P. Steensma, MD, Robert J. Soiffer, MD, Joseph H Antin, MD, Donna S Neuberg, ScD, Vincent T. Ho, MD, Richard M. Stone, MD

Blood (2015) 126 (23): 1304.

https://doi.org/10.1182/blood.V126.23.1304.1304

Published: 2015

Journal Articles

Higher Incidence of Treatment-Related Toxicities in Non-Hispanic Patients Undergoing Therapy for Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia on Dana-Farber Cancer Institute ALL Consortium Protocol 05-001

Justine Kahn, MD, Sergio Barrera, Randy Davila, Emily Roberts, ZheZhen Jin, PhD, Kristen Stevenson, MS, Traci M. Blonquist, MS, Donna S Neuberg, ScD, Uma H. Athale, MD, M.Sc., Luis A. Clavell, MD, Peter Cole, MD, Caroline Laverdiere, MD, Bruno Michon, MD FRCPC, Marshall A. Schorin, MD, Jennifer J.G. Welch, MD, Stephen E. Sallan, MD, Lewis B. Silverman, MD, Kara M. Kelly, MD

Blood (2015) 126 (23): 248.

https://doi.org/10.1182/blood.V126.23.248.248

Published: 2015

Journal Articles

Phase Ib Trial of the mTOR Inhibitor Everolimus Given in Combination with Multiagent Chemotherapy in Relapsed Acute Lymphoblastic Leukemia

Andrew E. Place, MDPhD, Yana Pikman, MD, Kristen Stevenson, MS, Marian H. Harris, MD PhD, Todd M. Cooper, DO, Lia Gore, MD, Nobuko Hijiya, MD, Mignon L. Loh, MD, Melinda Pauly, MD, Maria Luisa Sulis, MD, Donna S Neuberg, ScD, Kimberly Stegmaier, MD, Stephen E. Sallan, MD, Lewis B. Silverman, MD

Blood (2015) 126 (23): 3765.

https://doi.org/10.1182/blood.V126.23.3765.3765

Published: 2015

Journal Articles

Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee

Blood (2015) 126 (23): 907.

https://doi.org/10.1182/blood.V126.23.907.907

Published: 2015

Journal Articles

A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial

Daniel J. DeAngelo, MD PhD, Kristen Stevenson, MS, Donna S Neuberg, ScD, Lewis B. Silverman, MD, Karen K. Ballen, MD, Julie D. Asch, MD, Yasser Abou Mourad, MD, Kristjan Paulson, MD FRCPC, Matthew D. Seftel, MBChB, FRCP(C), MRCP, David Avigan, MD, Julie Bergeron, MD, Stephen Couban, MD, William Blum, MD, John Storring, MD, Martha Wadleigh, MD, David P. Steensma, MD, Jeffrey Supko, PhD, Stephen E. Sallan, MD, Richard M. Stone, MD

Blood (2015) 126 (23): 80.

https://doi.org/10.1182/blood.V126.23.80.80

Published: 2015

Journal Articles

The MDM2 Inhibitor NVP-CGM097 Is Highly Active in a Randomized Preclinical Trial of B-Cell Acute Lymphoblastic Leukemia Patient Derived Xenografts

Elizabeth C Townsend, PhD, Tiffany DeSouza, B.S., Mark A. Murakami, MD MA, Joan Montero, PhD, Kristen Stevenson, MS, Amanda L Christie, B.S., Alexandra N Christodolou, M.Sc., Una Vojinovic, B.S., Nadja Kopp, M.S., Patrizia Barzaghi-Rinaudo, Masato Murakami, MD, PhD, Anthony Letai, MD PhD, Sebastien Jeay, Jens Wuerthner, Ensar Halilovic, David M. Weinstock

Blood (2015) 126 (23): 797.

https://doi.org/10.1182/blood.V126.23.797.797

Published: 2015

Journal Articles

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

Rafael Bejar, Allegra Lord, Kristen Stevenson, Michal Bar-Natan, Albert Pérez-Ladaga, Jacques Zaneveld, Hui Wang, Bennett Caughey, Petar Stojanov, Gad Getz, Guillermo Garcia-Manero, Hagop Kantarjian, Rui Chen, Richard M. Stone, Donna Neuberg, David P. Steensma, Benjamin L. Ebert

Blood (2014) 124 (17): 2705–2712.

https://doi.org/10.1182/blood-2014-06-582809

Published: 2014

Includes: Supplemental data

Journal Articles

Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia

Mohini Rajasagi, Sachet A. Shukla, Edward F. Fritsch, Derin B. Keskin, David DeLuca, Ellese Carmona, Wandi Zhang, Carrie Sougnez, Kristian Cibulskis, John Sidney, Kristen Stevenson, Jerome Ritz, Donna Neuberg, Vladimir Brusic, Stacey Gabriel, Eric S. Lander, Gad Getz, Nir Hacohen, Catherine J. Wu

Blood (2014) 124 (3): 453–462.

https://doi.org/10.1182/blood-2014-04-567933

Published: 2014

Includes: Supplemental data

Journal Articles

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Blood (2014) 123 (9): 1293–1296.

https://doi.org/10.1182/blood-2013-10-531509

Published: 2014

Includes: Supplemental data

Journal Articles

Increased Dose Rituximab Followed by Maintenance Rituximab As Initial Therapy for Indolent B Cell Lymphomas: A Phase II Trial,

Jeffrey A. Barnes, MD, PhD, Kristen Stevenson, Ephraim P. Hochberg, MD, Tak Takvorian, MD, David C. Fisher, MD, Ann LaCasce, MD, Jennifer R. Brown, MD, PhD, Anuj K. Mahindra, MD, Donna Neuberg, ScD, Jeremy S. Abramson, MD

Blood (2011) 118 (21): 3716.

https://doi.org/10.1182/blood.V118.21.3716.3716

Published: 2011

Journal Articles

Validation of a Prognostic Model and the Impact of SF3B1 , DNMT3A , and Other Mutations in 289 Genetically Characterized Lower Risk MDS Patient Samples

Rafael Bejar, MD, PhD, Kristen Stevenson, Bennett Caughey, Omar Abdel-Wahab, MD, Naomi Galili, Ph.D., Guillermo Garcia-Manero, Hagop M Kantarjian, Azra Raza, MD, David P. Steensma, MD, Ross L Levine, MD, Donna Neuberg, ScD, Benjamin L. Ebert, MD, D.Phil

Blood (2011) 118 (21): 969.

https://doi.org/10.1182/blood.V118.21.969.969

Published: 2011

Journal Articles

Ex Vivo Expansion of Donor-Derived Anti-Tumor T Cells for CLL-Specific Adoptive Immunotherapy

Masayasu Naito, MD, PhD, Ursula Hainz, PhD, Kristen Stevenson, Anselmo Alonso, Ken-ichi Matsuoka, MD, PhD, Tesuro Sasada, MD, PhD, Donna Neuberg, ScD, Jerome Ritz, MD, Gordon J. Freeman, PhD, Catherine J Wu, MD

Blood (2011) 118 (21): 978.

https://doi.org/10.1182/blood.V118.21.978.978

Published: 2011

Journal Articles

Randomized Comparison of IV PEG and IM E. Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01

Lewis B. Silverman, MD, Kristen Stevenson, Lynda M Vrooman, MD, Jeffrey G Supko, PhD, Barbara Asselin, MD, Uma Athale, MD, Luis A. Clavell, MD, Peter Cole, MD, Kara M Kelly, MD, Caroline Laverdiere, MD, Bruno Michon, MD, FRCPC, Marshall A. Schorin, MD, Cindy Schwartz, MD, MPH, Donna Neuberg, ScD, Stephen E. Sallan, MD

Blood (2011) 118 (21): 874.

https://doi.org/10.1182/blood.V118.21.874.874

Published: 2011

Journal Articles

Large-Scale CLL Genome Analysis Reveals Novel Cancer Genes, Including SF3B1

Blood (2011) 118 (21): 463.

https://doi.org/10.1182/blood.V118.21.463.463

Published: 2011

Journal Articles

Point Mutations In Myelodysplastic Syndromes Are Associated with Clinical Features and Are Independent Predictors of Overall Survival

Rafael Bejar, MD, PhD, Kristen Stevenson, Omar Abdel-Wahab, MD, McConkey Marie, PhD, Katherine Lin, James Randall McAuley, Kevin Cheung, MD, Naomi Galili, Ph.D., Guillermo Garcia-Manero, MD, Hagop Kantarjian, MD, Azra Raza, MD, Ross Levine, MD, Donna Neuberg, ScD, Benjamin L. Ebert, MD, DPhil

Blood (2010) 116 (21): 300.

https://doi.org/10.1182/blood.V116.21.300.300

Published: 2010

Journal Articles

MYBL2 Is a Candidate Tumor Suppressor Gene In MDS

Stefan Heinrichs, Lily Conover, Carlos E. Bueso-Ramos, Outi Kilpivaara, Ross Levine, MD, Kristen Stevenson, Donna Neuberg, ScD, Rafael Bejar, MD, PhD, Benjamin L. Ebert, MD, DPhil, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, A. Thomas Look, MD

Blood (2010) 116 (21): 1865.

https://doi.org/10.1182/blood.V116.21.1865.1865

Published: 2010

Journal Articles

Markedly Reduced Overall Survival of CYP2C19 2/2 Homozygotes After Myeloablative Hematopoietic Stem Cell Transplantation

Stacy E Melanson, MD, PhD, Kristen Stevenson, MS, Haesook T Kim, PhD, Joseph H. Antin, MD, Vincent T Ho, MD, Jerome Ritz, MD, Robert J Soiffer, MD, Michael Court, BVSc, PhD, Frank Kuo, MD, PhD, Janina Longtine, MD, Petr Jarolim, MD, PhD

Blood (2010) 116 (21): 520.

https://doi.org/10.1182/blood.V116.21.520.520

Published: 2010

NARROW

SF3B1 -mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas

RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice

Patients over Age 40 with Ph-Negative Acute Lymphoblastic Leukemia Do Not Benefit from Allogeneic Transplant in First Remission. Retrospective Analysis from a Large Tertiary Center

Higher Incidence of Treatment-Related Toxicities in Non-Hispanic Patients Undergoing Therapy for Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia on Dana-Farber Cancer Institute ALL Consortium Protocol 05-001

Phase Ib Trial of the mTOR Inhibitor Everolimus Given in Combination with Multiagent Chemotherapy in Relapsed Acute Lymphoblastic Leukemia

Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee

A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial

The MDM2 Inhibitor NVP-CGM097 Is Highly Active in a Randomized Preclinical Trial of B-Cell Acute Lymphoblastic Leukemia Patient Derived Xenografts

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Increased Dose Rituximab Followed by Maintenance Rituximab As Initial Therapy for Indolent B Cell Lymphomas: A Phase II Trial,

Validation of a Prognostic Model and the Impact of SF3B1 , DNMT3A , and Other Mutations in 289 Genetically Characterized Lower Risk MDS Patient Samples

Ex Vivo Expansion of Donor-Derived Anti-Tumor T Cells for CLL-Specific Adoptive Immunotherapy

Randomized Comparison of IV PEG and IM E. Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01

Large-Scale CLL Genome Analysis Reveals Novel Cancer Genes, Including SF3B1

Point Mutations In Myelodysplastic Syndromes Are Associated with Clinical Features and Are Independent Predictors of Overall Survival

MYBL2 Is a Candidate Tumor Suppressor Gene In MDS

Markedly Reduced Overall Survival of CYP2C19 2/2 Homozygotes After Myeloablative Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only